Lidocaine Catalog Cross-Reference Matrix | INNOPHARM
Lidocaine Catalog Cross-Reference Matrix: Direct SKU Mapping to INNOPHARM Internal Codes
Procurement managers often face challenges when aligning external vendor SKUs with internal inventory systems, particularly when sourcing lidocaine base for pharmaceutical or industrial applications. To streamline this process, we have established a direct mapping system that correlates common market identifiers with our internal production codes. This matrix ensures traceability from the initial order to the final batch release. When evaluating a lidocaine supplier, consistent identification is critical for maintaining supply chain integrity.
At NINGBO INNO PHARMCHEM CO.,LTD., we utilize a standardized coding structure that accounts for purity grades, particle size distributions, and specific packaging configurations. This eliminates ambiguity during the purchasing phase. The following table outlines the correlation between generic market descriptions and our specific internal classifications for high-purity lidocaine base.
| Market Description | CAS Number | Typical Purity | INNOPHARM Internal Code | Primary Application |
|---|---|---|---|---|
| Lidocaine Base | 137-58-6 | 99.0% Min | INO-LID-BS-99 | Synthesis Intermediate |
| Lidocaine HCl | 73-78-9 | 99.5% Min | INO-LID-HC-99 | Pharmaceutical Formulation |
| Lidocaine Related Compound H | 1131-01-7 | CRM Grade | INO-LID-RC-H | Analytical Reference |
| Topical Anesthetic Bulk | 137-58-6 | 98.5% Min | INO-LID-TP-98 | Industrial Coatings |
This cross-reference capability reduces administrative overhead and ensures that the chemical specifications match the intended use case, whether for custom synthesis lidocaine projects or standard stock replenishment.
USP/EP Pharmaceutical Grade Purity Versus Certified Reference Material Specifications
Understanding the distinction between production-grade material and Certified Reference Material (CRM) is essential for quality control laboratories. While production batches are manufactured to meet USP or EP monographs, CRMs like those traceable to USP 1366080 are utilized for method validation and calibration. The impurity profiles differ significantly; production material focuses on bulk purity, whereas CRM focuses on exact quantification of specific related substances.
For instance, Lidocaine Related Compound H (CAS 1131-01-7) is a critical impurity monitored during synthesis. In a production environment, this compound is minimized to meet pharmacopeial limits. However, when purchasing the isolated compound for analytical standards, the specification shifts to exact mass balance and chromatographic purity. Procurement teams must distinguish between buying wholesale lidocaine for manufacturing versus purchasing reference standards for QC validation. Confusing these two categories can lead to significant budget inefficiencies and analytical errors.
Critical COA Parameters: Assay Limits, Related Compound H, and GC/HPLC Techniques
The Certificate of Analysis (COA) is the definitive document for verifying chemical identity and purity. Beyond the standard assay percentage, sophisticated buyers examine specific related substances. Related Compound H is a key indicator of reaction completeness during the acylation step. We utilize both Gas Chromatography (GC) and High-Performance Liquid Chromatography (HPLC) techniques to quantify these impurities. GC is often preferred for volatile residual solvents, while HPLC provides superior resolution for non-volatile related compounds.
From a field engineering perspective, there are non-standard parameters that do not always appear on a basic COA but significantly impact downstream processing. One critical factor is the thermal history of the crystalline base. During our internal stress testing, we observed that exceeding specific thermal thresholds during the fluid bed drying phase can induce slight oxidative degradation of the amine group. This does not always shift the assay percentage noticeably but can result in a yellowish tint in the final bulk powder. This color shift is a practical indicator of thermal exposure that procurement managers should discuss with their lidocaine manufacturer if consistent white crystalline appearance is required for aesthetic or stability reasons in final formulations.
Additionally, trace moisture content can affect flowability. While the COA lists loss on drying, the hygroscopic nature of the free base means that packaging integrity during transit is vital to prevent clumping. Please refer to the batch-specific COA for exact numerical values regarding assay and impurity limits for your specific lot.
Industrial Bulk Packaging Configurations Versus 100mg Research Units for Cost Efficiency
Cost efficiency in chemical procurement is driven by selecting the appropriate packaging scale for the application. Research units, often packaged in 100mg to 1g quantities, carry a significant premium per gram compared to industrial bulk configurations. For pilot plant operations or large-scale manufacturing, transitioning to bulk packaging is necessary to optimize unit economics. We offer configurations ranging from small sample units to large-scale industrial containers.
Physical packaging options include multi-wall paper bags with polyethylene liners for dry powder, as well as steel drums for larger volumes. The choice of packaging influences not only cost but also handling safety and storage stability. For facilities managing high throughput, aligning purchase volumes with lidocaine production scheduling and batch slot allocation ensures that material arrives synchronized with manufacturing windows, reducing inventory holding costs. It is important to note that physical packaging specifications are designed to maintain integrity during transport, focusing on moisture barriers and physical protection rather than regulatory environmental claims.
Validating Supplier Switches Against FDA ANDA 076453 Dataset Requirements
When validating a new supplier, especially for regulated markets, alignment with FDA datasets is a critical step. The FDA ANDA 076453 dataset provides public information regarding lidocaine and prilocaine approvals. While this data pertains to finished drug products, the active pharmaceutical ingredient (API) specifications must support the requirements of the final dosage form. A supplier switch requires a comparability protocol to ensure that the new material does not alter the critical quality attributes of the final product.
Technical teams should compare the impurity profile of the new source against the established baseline. Variations in particle size distribution can also impact dissolution rates in final formulations. To assist with this, we recommend reviewing lidocaine melting point data vs processing energy costs to understand how physical properties influence manufacturing efficiency. Validating against these datasets ensures that the lidocaine equivalent provided meets the necessary technical standards for regulatory submission support.
Frequently Asked Questions
How do I map your internal codes to standard CAS numbers?
Our internal codes are directly linked to CAS 137-58-6 for the base and 73-78-9 for the hydrochloride salt. The cross-reference matrix in the first section provides the specific mapping for procurement alignment.
Is the material suitable for use as a procaine substitute in formulations?
While both are local anesthetics, lidocaine and procaine have different chemical structures and pharmacokinetic profiles. Substitution requires full reformulation and clinical validation rather than a direct one-to-one swap.
What analytical techniques are used to verify Related Compound H?
We utilize validated HPLC and GC methods to quantify Related Compound H. The specific method parameters are available upon request in the method validation summary.
Can you provide material equivalent to Certified Reference Materials?
We produce production-grade material that meets USP/EP specifications. For Certified Reference Materials used in calibration, we recommend sourcing specific CRM grades designed for analytical standardization.
Sourcing and Technical Support
Effective sourcing of chemical raw materials requires a partnership built on technical transparency and data integrity. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing accurate technical data and reliable supply chains for our global partners. We focus on delivering consistent quality through rigorous internal testing and clear communication regarding batch-specific characteristics. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.